Freenome

Freenome is a diagnostics company founded in 2014 by Gabriel Ling and headquartered in San Francisco, California. The company develops blood-based tests for early cancer detection, leveraging machine learning and computational biology to identify cancer signals before clinical symptoms emerge. Freenome's mission centers on precision medicine and democratizing access to early cancer screening across diverse patient populations. The company combines advanced laboratory research with computational methods to detect and characterize cancer across multiple tumor types. Through its blend of genomics, artificial intelligence, and rigorous clinical validation, Freenome aims to shift cancer care toward earlier intervention and improved patient outcomes.